Pressure BioSciences, Inc. Share Price Nasdaq
Equities
US74112E1091
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2021 | 2M 160M | Sales 2022 | 1.73M 138M | Capitalization | 15.89M 1.27B |
---|---|---|---|---|---|
Net income 2021 | -20M -1.6B | Net income 2022 | -16M -1.28B | EV / Sales 2021 | 16.4 x |
Net Debt 2021 | 14.51M 1.16B | Net Debt 2022 | 20.53M 1.64B | EV / Sales 2022 | 21.1 x |
P/E ratio 2021 |
-0.68
x | P/E ratio 2022 |
-0.81
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 98.82% |
Latest transcript on Pressure BioSciences, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 31/07/78 | |
Edmund Ting
CTO | Chief Tech/Sci/R&D Officer | 70 | 23/04/06 |
Chief Tech/Sci/R&D Officer | 59 | 02/04/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 73 | 31/07/78 | |
Vito Mangiardi
BRD | Director/Board Member | 75 | 02/07/12 |
Michael Urdea
BRD | Director/Board Member | 71 | 07/02/13 |
1st Jan change | Capi. | |
---|---|---|
-4.84% | 182B | |
+0.56% | 110B | |
-3.35% | 68.11B | |
+2.39% | 50.53B | |
+9.36% | 44.8B | |
+2.98% | 40.7B | |
+24.51% | 32.3B | |
+3.43% | 26.53B | |
+13.95% | 25.02B |